Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Topmune
- Development stage
- Unknown
- Lead developer
- Austrak
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Topmune is a marketed multivitamin, mineral, and colostrum chewable tablet developed and distributed by the Hyderabad-based pharmaceutical marketing company Austrak. The supplement is formulated to support overall health, boost immune function, maintain energy levels, and promote vitality. Its comprehensive composition includes essential nutrients such as Zinc, Vitamin C, Vitamin D, Vitamin E, Selenium, Vitamin A, Biotin, Vitamin B6, Folic Acid, Vitamin B12, and Colostrum, which work synergistically to fulfill daily nutritional requirements and support growth.
- Brand names
- Topmune
Beyond the preview
Go deeper on Topmune.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Topmune.